Telmisartan
NDC 62332-088, Telmisartan, tablet, from Alembic Pharmaceuticals Inc..
- Product NDC
- 62332-088
- Status
- Listed
- Labeler
- Alembic Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202130
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62332-088 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TELMISARTAN40 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62332-088-30 | 62332008830 | 30 TABLET in 1 BOTTLE (62332-088-30) |
| 62332-088-91 | 62332008891 | 1000 TABLET in 1 BOTTLE (62332-088-91) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c62d424c-7630-413c-be2c-3932831c3f1dNADAC price for package 62332008830
GET /v1/drugs/nadac/62332008830
Use it
Look up 62332-088 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62332-088 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62332-088. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.